{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:18:11Z","timestamp":1791566291246,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ijmmb.2024.100736","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T06:45:17Z","timestamp":1728110717000},"page":"100736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Klebsiella pneumoniae infections and phage therapy"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2348-8945","authenticated-orcid":false,"given":"Alakh Narayan","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aprajita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmmb.2024.100736_bib1","article-title":"The Antimicrobial resistance: tackling a crisis for the health and wealth of nations","year":"2014","journal-title":"Review on Antimicrobial Resistance"},{"issue":"4","key":"10.1016\/j.ijmmb.2024.100736_bib2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1128\/CMR.11.4.589","article-title":"Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors","volume":"11","author":"Podschun","year":"1998","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.ijmmb.2024.100736_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4161\/viru.22718","article-title":"Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed","volume":"4","author":"Shon","year":"2013","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.ijmmb.2024.100736_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10096-010-1057-1","article-title":"Clinical and molecular epidemiology of extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan","volume":"30","author":"Chong","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.ijmmb.2024.100736_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-3099(16)30257-2","article-title":"Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study","volume":"17","author":"Grundmann","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.ijmmb.2024.100736_bib6","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.tim.2005.04.003","article-title":"Here a virus, there a virus, everywhere the same virus?","volume":"13","author":"Breitbart","year":"2005","journal-title":"Trends Microbiol"},{"issue":"4","key":"10.1016\/j.ijmmb.2024.100736_bib7","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/mmi.12134","article-title":"Long tail fibres of the novel broad\u2010host\u2010range T \u2010even bacteriophage S 16 specifically recognize S almonella OmpC","volume":"87","author":"Marti","year":"2013","journal-title":"Mol Microbiol"},{"issue":"4","key":"10.1016\/j.ijmmb.2024.100736_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnw002","article-title":"Host receptors for bacteriophage adsorption","volume":"363","author":"Bertozzi Silva","year":"2016","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ijmmb.2024.100736_bib9","first-page":"139","article-title":"Role of outer membrane proteins of Gram-negative bacteria in interaction with human organism","volume":"46","author":"Bugla-Ploskonska","year":"2007","journal-title":"Postepy Mikrobiol"},{"issue":"1","key":"10.1016\/j.ijmmb.2024.100736_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2958.2001.02357.x","article-title":"No syringes please, ejection of phage T7 DNA from the virion is enzyme driven","volume":"40","author":"Molineux","year":"2001","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.ijmmb.2024.100736_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.778676","article-title":"Evaluation of bacteriophage cocktail on septicemia caused by colistin-resistant Klebsiella pneumoniae in mice model","volume":"13","author":"Singh","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.ijmmb.2024.100736_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12866-018-1234-4","article-title":"The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model","volume":"18","author":"Manohar","year":"2018","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.ijmmb.2024.100736_bib13","first-page":"1","article-title":"Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice","volume":"2015","author":"Cao","year":"2015","journal-title":"BioMed Res Int"},{"issue":"1","key":"10.1016\/j.ijmmb.2024.100736_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14187","article-title":"A cocktail of three virulent bacteriophages prevents Vibrio cholerae infection in animal models","volume":"8","author":"Yen","year":"2017","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ijmmb.2024.100736_bib15","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.chom.2019.05.001","article-title":"Dynamic modulation of the gut microbiota and metabolome by bacteriophages in a mouse model","volume":"25","author":"Hsu","year":"2019","journal-title":"Cell Host Microbe"},{"issue":"9","key":"10.1016\/j.ijmmb.2024.100736_bib16","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.4049\/jimmunol.1701745","article-title":"Contribution of the immune response to phage therapy","volume":"200","author":"Krut","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.ijmmb.2024.100736_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jtbi.2017.06.037","article-title":"Modeling the synergistic elimination of bacteria by phage and the innate immune system","volume":"429","author":"Leung","year":"2017","journal-title":"J Theor Biol"},{"key":"10.1016\/j.ijmmb.2024.100736_bib18","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3389\/fmicb.2020.00414","article-title":"Impact of frequent administration of bacteriophage on therapeutic efficacy in an A. Baumannii mouse wound infection model","volume":"11","author":"Rouse","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijmmb.2024.100736_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/482863","article-title":"The effect of bacteriophage preparations on intracellular killing of bacteria by phagocytes","volume":"2015","author":"Jo\u0144czyk-Matysiak","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.ijmmb.2024.100736_bib20","article-title":"Combination therapy of phage vB_KpnM_P-KP2 and gentamicin combats acute pneumonia caused by K47 serotype Klebsiella pneumoniae","volume":"12","author":"Wang","year":"2021","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.ijmmb.2024.100736_bib21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41467-021-27656-z","article-title":"Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae","volume":"13","author":"Eskenazi","year":"2022","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.ijmmb.2024.100736_bib22","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/cid\/ciz222","article-title":"Successful treatment of antibiotic-resistant, poly-microbial bone infection with bacteriophages and antibiotics combination","volume":"69","author":"Nir-Paz","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijmmb.2024.100736_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/138920110790725401","article-title":"Phage therapy in clinical practice: treatment of human infections","volume":"11","author":"Kutter","year":"2010","journal-title":"Curr Pharmaceut Biotechnol"},{"key":"10.1016\/j.ijmmb.2024.100736_bib24","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fcimb.2018.00376","article-title":"Bacteriophage therapy: clinical trials and regulatory hurdles","volume":"8","author":"Furfaro","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10.1016\/j.ijmmb.2024.100736_bib25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4161\/bact.1.2.15845","article-title":"Phage treatment of human infections","volume":"1","author":"Abedon","year":"2011","journal-title":"Bacteriophage"},{"issue":"2","key":"10.1016\/j.ijmmb.2024.100736_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnv225","article-title":"A bacteriophage journey at the European Medicines Agency","volume":"363","author":"Debarbieux","year":"2016","journal-title":"FEMS Microbiol Lett"},{"issue":"2","key":"10.1016\/j.ijmmb.2024.100736_bib27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/v10020064","article-title":"The magistral phage","volume":"10","author":"Pirnay","year":"2018","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.ijmmb.2024.100736_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/v9030050","article-title":"A review of phage therapy against bacterial pathogens of aquatic and terrestrial organisms","volume":"9","author":"Doss","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.ijmmb.2024.100736_bib29","article-title":"Isolation of Klebsiella pneumoniae phage vB_KpnS_MK54 and pathological assessment of endolysin in the treatment of pneumonia mice model","volume":"13","author":"Lu","year":"2022","journal-title":"Front Microbiol"},{"issue":"5","key":"10.1016\/j.ijmmb.2024.100736_bib30","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/v12050545","article-title":"Antibiofilm activity of a broad-range recombinant endolysin LysECD7: in vitro and in vivo study","volume":"12","author":"Fursov","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ijmmb.2024.100736_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.748718","article-title":"Discovering the potentials of four phage endolysins to combat gram-negative infections","volume":"12","author":"Vasina","year":"2021","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.ijmmb.2024.100736_bib32","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3390\/v13040680","article-title":"The advantages and challenges of using endolysins in a clinical setting","volume":"13","author":"Murray","year":"2021","journal-title":"Viruses"},{"issue":"22","key":"10.1016\/j.ijmmb.2024.100736_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.02085-18","article-title":"Phage-antibiotic synergy via delayed lysis","volume":"84","author":"Kim","year":"2018","journal-title":"Appl Environ Microbiol"},{"issue":"4","key":"10.1016\/j.ijmmb.2024.100736_bib34","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/v10040188","article-title":"Characterizing phage genomes for therapeutic applications","volume":"10","author":"Philipson","year":"2018","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.ijmmb.2024.100736_bib35","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/22221751.2020.1747950","article-title":"Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant Klebsiella pneumoniae","volume":"9","author":"Bao","year":"2020","journal-title":"Emerg Microb Infect"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085724002111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085724002111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T19:28:18Z","timestamp":1734377298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085724002111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":35,"alternative-id":["S0255085724002111"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmmb.2024.100736","relation":{},"ISSN":["0255-0857"],"issn-type":[{"value":"0255-0857","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Klebsiella pneumoniae infections and phage therapy","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmmb.2024.100736","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100736"}}